Paul Thomen

Wednesday, 13 May 2015

Traumatic Brain Injury Pipeline Review and Market Report, H1 2015

Global Markets Direct’s, ‘Traumatic Brain Injury – Pipeline Review, H1 2015’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Traumatic Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Traumatic Brain Injury and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Complete report on H1 2015 pipeline review of “Traumatic Brain Injury” addition with 72 market data tables and 15 figures, spread across 265 pages is available . (This is a premium report price at US$2000 for a single user PDF license)
The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
·         The report provides a snapshot of the global therapeutic landscape of Traumatic Brain Injury
·         The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
·         The report reviews key players involved in the therapeutics development for Traumatic Brain Injury and enlists all their major and minor projects
·         The report summarizes all the dormant and discontinued pipeline projects
·         A review of the Traumatic Brain Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
·         Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
·         A detailed assessment of monotherapy and combination therapy pipeline projects
Inquire for discount on this report at .
Reasons to Buy:
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Traumatic Brain Injury
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Traumatic Brain Injury pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
More reports on Therapeutics :
Global Peritoneal Dialysis Market 2015-2019
Peritoneal dialysis is a needle-free treatment and can be performed either by a patient or with the help of a care partner. It is used to remove waste products and extra fluid from the body during the issue with kidney functions. Peritoneal dialysis differs from hemodialysis as in this treatment the blood is not taken from the body to treat the patient. In peritoneal dialysis, a tube called PD catheter is placed in the belly of the patient, and the dialysis is carried out by sterile fluid flowing through the lining of the belly called the peritoneum. This helps the blood flow into and out of the peritoneal space and the blood is cleansed inside the body.
Complete report is available at .

No comments:

Post a Comment

Note: only a member of this blog may post a comment.